Literature DB >> 11572087

Pituitary adenylate cyclase activating peptide (PACAP) immunoreactivity in the ureter of the duck.

N Mirabella1, C Squillacioti, G Germano, E Varricchio, G Paino.   

Abstract

The presence, distribution and colocalisation of pituitary adenylate cyclase activating peptide (PACAP) immunoreactivity have been studied in the duck ureter by using Western blot analysis, radioimmunoassays (RIA) and immunohistochemistry. The presence of both PACAP-38 and PACAP-27 was demonstrated, PACAP-38 being the predominant form. PACAP-immunoreactive fibres and neurons were found in all the ureteral layers. Double immunostaining showed that PACAP was almost completely colocalised with vasoactive intestinal peptide (VIP). Moreover, PACAP was found in substance P (SP)-containing ureteral nerve fibres and in SP-containing dorsal root ganglion neurons. RIA performed on denervated ureters demonstrated that almost half of the ureteral PACAP was extrinsic in origin. These findings suggest that, in birds, PACAP has a role in diverse nerve-mediated ureteral functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11572087     DOI: 10.1007/s004410100415

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  3 in total

1.  Expression of pituitary adenylate cyclase-activating polypeptide in the primary lymphoid organs of the duck Anas platyrhynchos.

Authors:  Caterina Squillacioti; Nicola Mirabella; Adriana De Luca; Giuseppe Paino
Journal:  J Anat       Date:  2006-07       Impact factor: 2.610

2.  Duck pancreatic acinar cell as a unique model for independent cholinergic stimulation-secretion coupling.

Authors:  Bi Jue Wang; Hui Yuan Liang; Zong Jie Cui
Journal:  Cell Mol Neurobiol       Date:  2009-04-16       Impact factor: 5.046

3.  Examination of PACAP-Like Immunoreactivity in Urogenital Tumor Samples.

Authors:  Andrea Tamas; Andras Javorhazy; Dora Reglodi; Donat Peter Sarlos; Daniel Banyai; David Semjen; Jozsef Nemeth; Beata Lelesz; Daniel Balazs Fulop; Zalan Szanto
Journal:  J Mol Neurosci       Date:  2015-10-10       Impact factor: 3.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.